Recommended – Venture Capital and Emerging CompaniesThe Legal 500 US 2016

Evan G. Smith

Boston
  • 200 Clarendon Street
  • Boston, MA 02116
  • USA
 
 

Evan Smith advises companies and their stakeholders in life sciences, healthcare, technology, and other sectors at every stage of growth and operations, from company conception through exit, and beyond for companies going public. This includes:

  • Early-stage entity formation and corporate structuring
  • Angel, venture capital, and growth financings
  • Licensing and other commercial and strategic transactions
  • Employment matters
  • Securities law compliance
  • Mergers and acquisitions
  • Public securities offerings

In addition to his client work, Mr. Smith is a member of the firm’s Diversity Leadership Committee and has served as Corporate Department Chair of Latham’s Boston office. He also led development of LathamDrive.com and edited Latham’s Emerging Companies Book of Jargon.


In addition to providing day-to-day corporate advice to many companies, Mr. Smith has advised:

Life Sciences/Healthcare
  • Baird Capital in venture capital investments
  • Boston Scientific in strategic investments in private companies
  • Cytrellis Biosystems in venture capital financings
  • DigitalOptometrics in strategic and growth financings
  • Fractyl Laboratories in venture capital financings
  • IntelyCare in venture capital financings
  • Immuneering Corporation in its:
    • Venture capital financings
    • Combination with Teva Pharmaceuticals
    • Initial public offering
    • Periodic reports and public filings
  • Kate Farms Inc. in growth financings
  • Laminar, Inc. in angel and venture capital financings
  • T2 Biosystems in its:
    • Initial public offering
    • Periodic reports and public filings
    • Takedown offerings
  • Topera in its merger with Abbott Laboratories
Technology/Other
  • A123 Systems in its merger with Wanxiang America and Navitas Systems
  • A Cloud Guru in its:
    • Venture capital financings
    • Acquisition of Linux Academy
    • Sale to Pluralsight
  • Ava Labs in corporate matters and token offerings
  • Cartera Commerce in its merger with Ebates (Rakuten)
  • Copiun in its:
    • Venture capital financings
    • Merger with Good Technology
  • Cherre Inc. in early stage and growth financings
  • Drizly in its formation and:
    • Venture capital financings
    • Sale to Uber Technologies for US$1.1 billion
  • Education.com in its sale to IXL Learning
  • The underwriters in the initial public offering of EverQuote
  • The Farmer’s Dog in venture capital financings
  • Gaia Design in venture capital financings
  • Ipswitch in its merger with Progress
  • IXL Learning in its
    • Acquisition of Rosetta Stone Languages
    • Acquisition of Wyzant
  • Micronetics in its merger with Mercury Computer Systems
  • Network Engines in its merger with UNICOM Systems
  • RealBlocks in early stage and venture capital financings
  • Revelops (Logentries) in its merger with Rapid7
  • Synack in venture capital financings
  • Twitch Interactive, Inc. in its US$970 million merger with Amazon.com, Inc.
  • TravelPerk in early stage and venture capital financings

 

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.